01 August 2007
Facial transplantation: Understanding the interests of patients and hurdles to informed consent
Michael HurlburtMed Sci Monit 2007; 13(8): RA147-153 :: ID: 491816
Abstract
Facial transplantation for persons with severe facial deformity has sparked much debate in the bioethics community. Unfortunately, the primary ethical issues stemming from facial transplantation have been neglected in the flurry of published literature, resulting in a lopsided and inadequate evaluation of the interests of patients and our responsibilities to them. In this essay, I shall address the major concerns raised by those who believe that it would be unethical to allow persons with disfigured faces to undergo facial transplantation. Most critics have argued hastily that the experimental nature of this procedure makes it impossible for patients to provide informed consent. I shall demonstrate that this judgment is misguided and that patients can be sufficiently educated about the procedure’s seemingly unique potential risks and benefits. Upon proving the hurdles to providing informed consent are surmountable, I shall establish that the worries held by opponents of facial transplantation do not justify withholding this procedure from disfigured persons. I shall explain that there is sufficient understanding of the possible outcomes of facial transplantation to ensure that the interests of patients will be given proper consideration, and that given our concern for the autonomy and well-being of patients, facial transplantation should be made available to suitable persons with drastic facial deformity.
Keywords: Consent Forms, Tissue Transplantation - methods, Risk, Quality of Life, Informed Consent, Human Experimentation, Face - pathology, Ethics, Medical, Face - pathology, Tissue Transplantation - methods, Risk, Quality of Life, Informed Consent, Human Experimentation, Consent Forms, Ethics, Medical
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952